MedTrace Logo

Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes

NCT02138006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2016-10-24

Study results available
· View outcomes & findings →

Summary

To investigate long-term effects on cardiovascular mortality/morbidity and renal failure in type 1 diabetes patients former randomized to intensive insulin treatment

Conditions

Interventions

DRUG

Intensive insulin treatment

Mealtime insulin (Actrapid) Basal insulin (Monotard)

DRUG

Standard insulin treatment

Insulin Mixtard

Sponsors & Collaborators

Principal Investigators

  • Thomas Nyström, Md, PhD · Karolinska Institutet Dept of clinical science and education Södersjukhuset Stocholm

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
52 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1982-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02138006 on ClinicalTrials.gov